Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

432.72
Delayed Data
As of Sep 22
 -0.73 / -0.17%
Today’s Change
325.35
Today|||52-Week Range
543.55
+17.88%
Year-to-Date
Stalking Regeneron for Key Low and Reversal
7:03am / TheStreet.com - Paid Partner Content
Lilly/Incyte's Baricitinib Meets Endpoint in Eczema Study
Sep 15 / Zacks.com - Paid Partner Content
The Medicines Co. Continues to Focus on Pipeline Development
Sep 22 / Zacks.com - Paid Partner Content
Glaxo's Shingles Candidate Gets Positive FDA Committee Vote
Sep 14 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Focuses on Pipeline Development & Acquisitions
Sep 22 / Zacks.com - Paid Partner Content
Alexion (ALXN) Reports Interim Results for Soliris Study
Sep 14 / Zacks.com - Paid Partner Content
Alnylam/Sanofi's RNAi Drug Meets Endpoint in Study, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
Alexion to Restructure Operations, to Lower Headcount by 20%
Sep 13 / Zacks.com - Paid Partner Content
How is the Age-Related Macular Degeneration Space Faring Now?
Sep 21 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer ...
Sep 13 / Zacks.com - Paid Partner Content
ProQR's Genetic Disorder Candidate Gets Orphan Drug Status
Sep 20 / Zacks.com - Paid Partner Content
Achillion's HCV Partnership with J&J Terminated, Stock Falls
Sep 12 / Zacks.com - Paid Partner Content
Teva/Nuvelution to Speed Up Development of Austedo in US
Sep 20 / Zacks.com - Paid Partner Content
AstraZeneca's Asthma Candidate Shows Promising Results
Sep 12 / Zacks.com - Paid Partner Content
Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia
Sep 19 / Zacks.com - Paid Partner Content
Pfizer Lung Cancer Drug's Overall Survival Data Unfavorable
Sep 12 / Zacks.com - Paid Partner Content
Pluristem's Ischemia Candidate Gets Fast Track Designation
Sep 19 / Zacks.com - Paid Partner Content
AstraZeneca's Lung Cancer Study Data Promising, Shares Spike
Sep 11 / Zacks.com - Paid Partner Content
Zacks.com featured highlights include include Hasbro, Regeneron Pharmaceuticals, Appl...
Sep 19 / Zacks.com - Paid Partner Content
Regeneron/Sanofi's Dupixent Asthma Study Meets Endpoints
Sep 11 / Zacks.com - Paid Partner Content
Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU
Sep 18 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for September 11th
Sep 11 / Zacks.com - Paid Partner Content
5 Top Stocks with Impressive Sales Growth Worth Betting On
Sep 18 / Zacks.com - Paid Partner Content
Roche's Ophthalmology Drug Fails to Meet Primary Endpoint
Sep 11 / Zacks.com - Paid Partner Content
Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study
Sep 15 / Zacks.com - Paid Partner Content
5 Top-Ranked Biotech Stocks to Buy Right Now
Sep 11 / Zacks.com - Paid Partner Content